IL1B and necrotizing enterocolitis: SHMOs at the concentration of 1500 mg/L, which is within the physiological range as reported in human milk, improved rat survival and prevented the intestinal inflammatory lesions in response to hypoxia/cold stress as indicated by decreased NEC scores and ileum concentrations of IL-1β, IL-6 and TNF-α.